# How Long Ipamorelin Stays in Your System: Half-Life and Clearance

> How long does ipamorelin stay in your system: the human terminal half-life is about 2 hours, with clearance 0.078 L/h/kg and a GH pulse peaking near 40 minutes. The pharmacokinetic detail, cited to the source study.

The terminal half-life is about 2 hours in human volunteers — here is what that number means and where it comes from.

## The short answer

How long does ipamorelin stay in your system? In the one human study that measured it, the terminal half-life — the time for the blood level to drop by half once it starts clearing — was about two hours [2]. A useful rule of thumb in pharmacology is that a drug is mostly gone after four to five half-lives, which for ipamorelin works out to roughly eight to ten hours before the blood level falls to a small fraction of its peak. That is the *drug* clearing. The *effect* — a single burst of growth hormone — is even shorter-lived, peaking around forty minutes after a dose and then subsiding [2]. So the honest answer has two parts: the peptide itself is cleared within hours, and the hormone pulse it causes is briefer still. Every number on this page traces back to the same human pharmacokinetic study.

## The terminal half-life: about 2 hours

The figure comes from population pharmacokinetic-pharmacodynamic modeling in healthy male volunteers, n=8 per dose level, given five 15-minute intravenous infusions spanning 4.21 to 140.45 nmol/kg. The kinetics were linear and dose-proportional, and the terminal half-life was approximately 2 hours [2]. Dose-proportional means doubling the dose roughly doubled the exposure without changing the half-life — a clean, predictable profile.

This is an intravenous half-life. By the subcutaneous route that dominates community use, the absorption phase adds time at the front end, so the apparent duration can be longer than the pure 2-hour elimination figure — but no controlled human subcutaneous pharmacokinetic study has characterized that, so the only defensible human half-life number remains the ~2-hour intravenous value [2].

## Clearance and volume of distribution

Two further parameters fill in the picture. Plasma clearance — how much blood is fully cleared of the drug per unit time — was 0.078 L/h/kg, and the steady-state volume of distribution was 0.22 L/kg [2]. A volume of distribution near 0.2 L/kg is small, roughly consistent with the compound staying largely in the extracellular fluid rather than distributing widely into tissues, which fits a small, water-soluble peptide.

In rats, plasma clearance is roughly 5-fold lower than that of GHRP-6, a related peptide — a comparative note that helps place ipamorelin's handling within its class [2]. Together, the half-life, clearance, and volume figures are the quantitative core of any due-diligence reading of how the body processes ipamorelin.

## Detection is a separate question from clearance

"Stays in your system" can mean two different things: how long the compound exerts an effect, and how long a laboratory can *detect* it. These are not the same. While the active half-life is about 2 hours, accredited anti-doping laboratories can detect ipamorelin and its metabolites in urine using sensitive methods — direct-urine-injection ion-mobility mass spectrometry achieves limits of detection of 50-500 pg/mL [12], and ipamorelin's urinary metabolite pattern after administration has been characterized [10]. Detection windows depend on dose, route, and assay sensitivity and are not the same as the pharmacokinetic half-life. For anyone subject to anti-doping testing, the relevant point is that ipamorelin is prohibited at all times under WADA category S2 and is reliably detectable, well after its pharmacological effect has passed.

---

A pharmacokinetics-first due-diligence read of the ipamorelin record — the ~2-hour human half-life and the clearance figures logged as the one clean instrument reading, the failed Phase 2 endpoint and the 503A/WADA status entered straight from the register, and the community reports held to one side as unverified; no clinic behind the readout, no endorsement of any seller, and nothing here dosed, prescribed, or sold.
